cathepsin K inhibitors (Ciba-Geigy)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecathepsin K inhibitors (Ciba-Geigy)
Drug Alias Namecathepsin Kcathepsin K inhibitors (Novartis)NVP-AAR494
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCiba-Geigy Japan Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCiba-Geigy Japan Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A